Management of the australianclinicaltrials.gov.au website has been transferred from NHMRC to the Commonwealth Department of Health. Disruption to site users as a consequence of this change should be minimal. Users should note that email notifications coming from the website will come from australianclinicaltrials@health.gov.au from Friday the 8th of April 2022. Any user experiencing difficulty as a result of this change should direct enquiries to australianclinicaltrials@health.gov.au for assistance.

Clinical Trial Details

Comparing Outpatient and Inpatient Autologous Stem Cell Transplant in Patients with Multiple Myeloma

Print record Print record
Trial Information

Broad Health Condition Cancer
Public Health

Specific Health ConditionMyeloma
Health service research

Trial FocusTreatment

Recruitment statusRecruiting

Recruitment Details
Recruitment State
NSW

Hospital
Nepean Hospital - Kingswood


Postcode
2747 - Kingswood

Phase of TrialNot Applicable

Has the study received ethics approval?Further information iconApproved

Trial summary

The purpose of this study is to examine the safety of completing a stem cell transplant of your own cells in the outpatient setting.
Who is it for?
You may be eligible for this study if you are aged 18 -75 and are undergoing a stem cell transplant with your own cells at Nepean Hospital.
Study Details
Participants will choose between two locations for their transplant, inpatient or outpatient. 
Inpatient participants will receive all pre-transplant, transplant and post transplant care in hospital. Inpatient participants will be discharged when they are well enough.
Outpatient participants will come to the centre for their pre-transplant chemotherapy, transplant and post transplant care but be able to stay at home between visits until they become unwell or require extra care unable to be provided at home. The outpatient participants will also take oral antibiotics after the transplant.
As part of this study, participants and their carers will complete questionnaires and consent to study staff reviewing their medical records.
It is hoped this research will show that stem cell transplant can be performed in an outpatient setting, which may improve quality of life.
Eligibility

Key inclusion criteria

diagnosis of multiple myeloma
to be treated with Melphalan pre-transplant
ECOG 0,1,or 2
Fit for autologous stem cell transplant at Nepean Hospital
Participant willing to participate in the trial
carer available
transport and driver available
complies with cohort distance requirements

Minimum age18 Years

Maximum age75 Years

GenderBoth males and females

Can Healthy volunteers participate?No

Key exclusion criteria

Not fit for Autologous stem cell transplant
Unwilling to participate
Contact details and further information

Sponsor Primary Sponsor Type: Government body
Primary Sponsor Name: Nepean Blue Mountains Local Health District
Primary Sponsor Address: Cnr Great Western Hwy and Somerset St Kingswood NSW 2747
Primary Sponsor Country: Australia

Trial IDACTRN12620000667910

UTNNil

Contact person for information and recruitmentMs
Elyssa Deakin
Nepean Cancer Care Centre Cnr Great Western Hwy and Somerset St Kingswood NSW 2747
+61 2 4734 4411

Further information iconelyssa.deakin@health.nsw.gov.au
Australia